More On

Eli Lilly Wins Patent Protection

Eli Lilly faced some significant hurdles in 2006. After losing $65 million in a patent dispute against competitor Ariad Pharmaceuticals Inc., the pharmaceutical giant faced another scare over the possibility of losing its patent on its blockbuster antipsychotic drug Zyprexa.

However, Lilly's luck changed Dec. 26, when the U.S. Court of Appeals for the Federal Circuit affirmed a lower court's ruling that found the patent valid.

staff Writer

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.